4.6 Article

Tautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1-42)

期刊

ACS CHEMICAL NEUROSCIENCE
卷 8, 期 3, 页码 669-675

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.6b00375

关键词

Tautomeric effect; amyloid(1-42) peptide; histidine tautomer; sheet structure; protein misfolding; aggregation

资金

  1. National Research Foundation (NRF) grants - Ministry of Education, Science and Technology [2012M3C1A6035359]
  2. KISTI supercomputing center through the strategic support program for the supercomputing application research [KSC-2014-C2-056]
  3. National Research Foundation of Korea [2012M3C1A6035359] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Tautomeric state of histidine is one of the factors that influence the structural and aggregation properties of amyloid beta (A beta)-peptide in neutral state. It is worth it to uncover the monomeric properties of A beta(1-42) peptide in comparison with A beta(1-40) peptide. Our replica-exchange molecular dynamics simulations results show that the sheet content of each tautomeric isomer in A beta(1-42) monomer is slightly higher than that in A beta(1-40) monomer except His6(delta)-His13(delta)-His14(delta) (delta delta delta) isomer, implying higher aggregation tendency in A beta(1-42), which is in agreement with previous experimental and theoretical studies. Further analysis indicates that (epsilon epsilon epsilon), (epsilon delta epsilon), (epsilon delta delta), and (delta delta epsilon) isomers prefer sheet conformation although they are in nondominating states. Particularly, it is confirmed that antiparallel beta-sheets of (epsilon delta delta) were formed at K16-E22 (22.0-43.9%), N27-A30 except G29 (21.9-40.2%), and M35-141 except G37 (24.1-43.4%). Furthermore, (eSO) may be the easiest one to overcome structural transformation due to nonobstructing interactions between K16 and/or L17 and histidine residues. The current study will help to understand the tautomeric effect of A beta(1-42) peptide to overcome Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据